159 related articles for article (PubMed ID: 34313294)
41. Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators.
Schwarz B; Sharma L; Roberts L; Peng X; Bermejo S; Leighton I; Casanovas-Massana A; Minasyan M; Farhadian S; Ko AI; ; Dela Cruz CS; Bosio CM
J Immunol; 2021 Jan; 206(2):329-334. PubMed ID: 33277388
[TBL] [Abstract][Full Text] [Related]
42. Highlights from a year in a pandemic.
Merad M; Vabret N
J Exp Med; 2021 May; 218(5):. PubMed ID: 33835146
[TBL] [Abstract][Full Text] [Related]
43. Iron metabolism in infections: Focus on COVID-19.
Girelli D; Marchi G; Busti F; Vianello A
Semin Hematol; 2021 Jul; 58(3):182-187. PubMed ID: 34389110
[TBL] [Abstract][Full Text] [Related]
44. Targeted lipidomics data of COVID-19 patients.
Costanzo M; Caterino M
Data Brief; 2023 Jun; 48():109089. PubMed ID: 37006392
[TBL] [Abstract][Full Text] [Related]
45. Broader approaches are necessary for containing pandemics like covid-19.
Bhargava A
BMJ; 2021 Sep; 374():n2107. PubMed ID: 34470775
[No Abstract] [Full Text] [Related]
46. A high-throughput lipidomics and transcriptomic approach reveals novel compounds from sugarcane linked with promising therapeutic potential against COVID-19.
Rao MJ; Tahir Ul Qamar M; Wang D; Ali Q; Ma L; Han S; Duan M; Hu L; Wang L
Front Nutr; 2022; 9():988249. PubMed ID: 36118771
[TBL] [Abstract][Full Text] [Related]
47. Finding Hope after Pandemic Losses.
Thomas SP
Issues Ment Health Nurs; 2022 Jun; 43(6):497. PubMed ID: 35617056
[No Abstract] [Full Text] [Related]
48. A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants.
Farley SE; Kyle JE; Leier HC; Bramer LM; Weinstein J; Bates TA; Lee JY; Metz TO; Schultz C; Tafesse FG
bioRxiv; 2022 Feb; ():. PubMed ID: 35194611
[TBL] [Abstract][Full Text] [Related]
49. SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum.
Bruzzone C; Bizkarguenaga M; Gil-Redondo R; Diercks T; Arana E; García de Vicuña A; Seco M; Bosch A; Palazón A; San Juan I; Laín A; Gil-Martínez J; Bernardo-Seisdedos G; Fernández-Ramos D; Lopitz-Otsoa F; Embade N; Lu S; Mato JM; Millet O
iScience; 2020 Oct; 23(10):101645. PubMed ID: 33043283
[TBL] [Abstract][Full Text] [Related]
50. Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection.
Mandato C; Vajro P
Med Hypotheses; 2021 Apr; 149():110529. PubMed ID: 33621842
[No Abstract] [Full Text] [Related]
51. Growing Pains During COVID-19.
Kitto S
J Contin Educ Health Prof; 2022 Jan; 42(1):2-3. PubMed ID: 35225826
[No Abstract] [Full Text] [Related]
52. Lipidomics Issues on Human Positive ssRNA Virus Infection: An Update.
Balgoma D; Gil-de-Gómez L; Montero O
Metabolites; 2020 Aug; 10(9):. PubMed ID: 32878290
[TBL] [Abstract][Full Text] [Related]
53. From the editor: Connectedness and lipidology.
Guyton JR
J Clin Lipidol; 2020; 14(5):611. PubMed ID: 33138959
[No Abstract] [Full Text] [Related]
54. COVID-19 Clinics: How It All Started.
Bernhardt JM; Chu J; Seelen M
J Ambul Care Manage; 2022 Oct-Dec 01; 45(4):341-342. PubMed ID: 36006391
[No Abstract] [Full Text] [Related]
55. Can a plant-based diet help mitigate Covid-19?
Kahleova H; Barnard ND
Eur J Clin Nutr; 2022 Jul; 76(7):911-912. PubMed ID: 35064220
[No Abstract] [Full Text] [Related]
56. It is all about the Structure.
Khayat R; Russell RS
Viral Immunol; 2021; 34(1):1-2. PubMed ID: 33507134
[No Abstract] [Full Text] [Related]
57. The trans-omics landscape of COVID-19.
Wu P; Chen D; Ding W; Wu P; Hou H; Bai Y; Zhou Y; Li K; Xiang S; Liu P; Ju J; Guo E; Liu J; Yang B; Fan J; He L; Sun Z; Feng L; Wang J; Wu T; Wang H; Cheng J; Xing H; Meng Y; Li Y; Zhang Y; Luo H; Xie G; Lan X; Tao Y; Li J; Yuan H; Huang K; Sun W; Qian X; Li Z; Huang M; Ding P; Wang H; Qiu J; Wang F; Wang S; Zhu J; Ding X; Chai C; Liang L; Wang X; Luo L; Sun Y; Yang Y; Zhuang Z; Li T; Tian L; Zhang S; Zhu L; Chang A; Chen L; Wu Y; Ma X; Chen F; Ren Y; Xu X; Liu S; Wang J; Yang H; Wang L; Sun C; Ma D; Jin X; Chen G
Nat Commun; 2021 Jul; 12(1):4543. PubMed ID: 34315889
[TBL] [Abstract][Full Text] [Related]
58. Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows.
Mussap M; Fanos V
Clin Chem Lab Med; 2021 Nov; 59(12):1891-1905. PubMed ID: 34332518
[TBL] [Abstract][Full Text] [Related]
59. Metabolomics in the Diagnosis and Prognosis of COVID-19.
Hasan MR; Suleiman M; Pérez-López A
Front Genet; 2021; 12():721556. PubMed ID: 34367265
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
